Target intelligence / Profile preview

5'-adenosine monophosphate-activated protein kinase (AMPK) (AMPK)

Target
AMPK
Molecular classification
Enzyme, Serine/threonine-protein kinase
01

Overview

5'-adenosine monophosphate-activated protein kinase (AMPK) is a highly conserved heterotrimeric enzyme complex that serves as the central sensor of cellular energy status across all eukaryotic species (Hardie, 2014 [4]). It is activated in response to energy stress, signaled by rising ratios of AMP:ATP or ADP:ATP, which occur during nutrient deprivation, hypoxia, or physical exertion (Winder & Thomson, 2007 [2]). Upon activation, AMPK restores metabolic homeostasis by stimulating catabolic pathways that produce ATP, such as glucose uptake and fatty acid oxidation, while simultaneously inhibiting anabolic pathways that consume ATP, including the synthesis of fatty acids, cholesterol, and proteins (Inoki et al., 2012 [6]). This 'master switch' function makes AMPK a primary therapeutic target for metabolic disorders like type 2 diabetes and obesity, where its activation improves glucose sensitivity and lipid profiles (Inoki et al., 2012 [6]). Furthermore, AMPK is an area of intense research in oncology and neurodegeneration due to its ability to modulate cell growth, autophagy, and mitochondrial health (Hardie, 2014 [4]; [13]).

Other names
Energy sensorMetabolic master switchAMP-activated protein kinaseAdenosine 5'-monophosphate-activated protein kinase
02

Mechanism of action

AMPK is activated by an increase in the cellular AMP:ATP ratio, leading to the phosphorylation of downstream targets such as ACC (Acetyl-CoA carboxylase) and TBC1D1, which promotes ATP-generating catabolic processes and inhibits ATP-consuming anabolic processes.

03

Biological functions

Energy homeostasisGlucose metabolismLipid metabolismAutophagyCellular response to stressCell cycle regulation
04

Disease associations

Type 2 diabetesObesityMetabolic syndromeCancerCardiovascular diseaseNeurodegenerative disease
05

Safety considerations

Potential for cardiac hypertrophy with chronic systemic activation of specific isoformsSuppression of biosynthetic pathways necessary for normal cell growth and tissue repairOff-target metabolic effects in non-target tissues
06

Interacting drugs

Metformin

4 more in the full profile.

07

Biomarkers

Phospho-AMPK (Thr172)Phospho-acetyl-CoA carboxylase (p-ACC)AMP:ATP ratioADP:ATP ratio

Beyond the preview

Go deeper on 5'-adenosine monophosphate-activated protein kinase (AMPK) (AMPK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5'-adenosine monophosphate-activated protein kinase (AMPK) (AMPK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call